Today: 1 May 2026

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs shares fell about 5% to $69.22 in early Friday trading, reversing part of a 10% gain earlier in the week. The drop came as broader U.S. markets rose on a softer December jobs report. Investors are watching for updates at the company’s Jan. 14 J.P. Morgan Healthcare Conference presentation and awaiting FDA review of its Motiva breast implants.
9 January 2026
·
Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Nvidia shares rose 0.1% to $185.31 Friday after Reuters reported the company now requires full upfront payment from Chinese buyers for H200 AI chips, with no cancellations or refunds allowed. Chinese tech firms have ordered over 2 million H200 chips, outstripping Nvidia’s inventory of about 700,000. Beijing has asked some firms to halt orders as it reviews conditions, even as U.S. export licenses are still pending.
9 January 2026
·
XRP price slips near $2 after Ripple’s UK FCA win — what traders watch next

XRP price slips near $2 after Ripple’s UK FCA win — what traders watch next

XRP dropped 1.9% to $2.09 Friday, while bitcoin and ether also slipped, as traders weighed Ripple’s UK approval for an electronic-money licence and cryptoasset registration. Coinbase fell 2.4% and Robinhood 0.4%. U.S. nonfarm payrolls rose 50,000 in December, missing forecasts. Investors await the Jan. 13 U.S. CPI report and the Federal Reserve’s Jan. 27-28 meeting.
9 January 2026
··
SLV stock jumps as silver price nears $80 after softer U.S. jobs data

SLV stock jumps as silver price nears $80 after softer U.S. jobs data

iShares Silver Trust (SLV) surged 3.4% to $72.11 in New York Friday, tracking a 3.9% jump in spot silver after U.S. payrolls data missed forecasts and fueled bets on Fed rate cuts. Spot silver was on pace for a 10% weekly gain. Pan American Silver rose 1.8%, First Majestic Silver 4.3%. U.S. CPI data is due Jan. 13.
9 January 2026
Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Spot gold rose 0.6% to $4,502.98 an ounce Friday after U.S. payrolls data missed forecasts, pushing bullion near record highs. SPDR Gold Shares gained 0.3%, while Newmont, Agnico Eagle, and Franco-Nevada advanced. Investors await U.S. Supreme Court tariff rulings Jan. 14 and the Fed’s Jan. 27-28 meeting for further policy signals.
9 January 2026
······
Vistra stock jumps as Meta locks in 20-year nuclear power deal for AI data centers

Vistra stock jumps as Meta locks in 20-year nuclear power deal for AI data centers

Vistra shares rose 11% to $167.11 by midday Friday after Meta signed 20-year nuclear power purchase agreements for 2,609 MW, with deliveries starting in late 2026. The deals cover Vistra’s Perry, Davis-Besse, and Beaver Valley plants. Investors focused on capital spending for upgrades and license extensions. Meta aims to secure power for its Ohio data center and future AI operations.
9 January 2026
·····
Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings shares dropped 4.5% to $17.32 in Friday afternoon trading, hitting a session low of $17.21. FinVolution and LexinFintech also declined, as investors weighed U.S. tariff uncertainty and concerns over rising Chinese consumer loan defaults. China’s regulator recently extended a program for banks to offload bad loans. The broader U.S. market traded higher.
9 January 2026
·····
Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Soleno Therapeutics shares fell 5.6% to $42.95 Friday, underperforming the biotech sector after law firms announced “investigations” tied to past short-seller claims about Vykat XR. The company reported $66 million in quarterly revenue from the drug, approved for Prader-Willi syndrome, with 1,043 patient start forms since March. The stock hovered just above its 52-week low. Next update expected late February.
9 January 2026
··
Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

Bitcoin slipped 0.5% to about $90,700 Friday, while Coinbase fell 2% and Strategy nearly 5% in U.S. trading. Ether and XRP also declined. Investors pulled nearly $885 million from U.S. spot bitcoin ETFs over two days this week. Traders are watching U.S. inflation data due Jan. 13 and the Fed’s Jan. 27-28 meeting.
9 January 2026
······
IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN shares rose 4.6% to $47.76 Friday, trading between $45.52 and $49.99 in heavy volume. Bernstein analyst Gautam Chhugani named IREN his top AI pick for 2026, according to TipRanks. Investors are watching for February earnings and signs of capital needs tied to the company’s AI expansion. IREN operates renewable-powered data centers in Canada and Texas and signed a $9.7 billion AI cloud deal with Microsoft last year.
9 January 2026
···
Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences shares dropped 5.6% to $14.00 on Friday, underperforming biotech ETFs. The decline follows a $350 million stock offering and comes ahead of new obesity drug trial data expected later in 2026. Investors remain focused on dilution risks and upcoming updates from management. CEO Paul Bolno will present at the J.P. Morgan Healthcare Conference on January 13.
9 January 2026
·
Applied Materials stock jumps toward $300 as TSMC sales beat and analysts lift AMAT targets

Applied Materials stock jumps toward $300 as TSMC sales beat and analysts lift AMAT targets

Applied Materials shares jumped about 6% Friday, briefly topping $300, after TSMC reported fourth-quarter revenue above forecasts. Other chip-equipment stocks also rose, with Lam Research up 8% and KLA up 5%. Investors are watching TSMC’s Jan. 15 outlook and Applied’s next earnings report for signs on 2026 spending.
9 January 2026
·····
1 … 735 736 737 738 739 … 1,886

Stock Market Today

  • Wall Street April Rally Marks Best Month Since Pandemic Rebound
    May 1, 2026, 6:55 AM EDT. Stocks surged in April with the S&P 500 rising over 10%, its best month since November 2020, and the Nasdaq Composite jumping more than 15%, the strongest since April 2020. The Nasdaq 100 posted its best month since October 2002, led by tech and semiconductor stocks. The PHLX Semiconductor Index surged 40%, reaching record highs with an 18-day winning streak. Intel, AMD, Micron, and Texas Instruments all posted their best months in over two decades. Alphabet, Amazon, Nvidia, and Broadcom each added hundreds of billions of dollars in market value. However, gains were concentrated in a few large stocks, while energy and healthcare sectors lagged. The challenge for May is whether smaller stocks can share the rally's momentum.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 6:56 AM EDT Babcock, Rolls-Royce and BAE Systems Shares Slump Amid High Valuations and Profit-Taking May 1, 2026, 6:56 AM EDT. April saw a sharp decline in shares of **defence giants BAE Systems** (-12.5%) and **Babcock International** (-14.8%) despite high order backlogs exceeding £80bn and £10bn respectively. **Rolls-Royce**, with a broader business including aerospace and power systems, posted strong Q1 results and saw a 7.6% day gain but still ended April down 7.56%. The FTSE 100 remained flat, ruling out a market-wide cause. Experts point to **profit-taking and
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop